The present technology describes a novel oral drug delivery system for drug resistance gastric cancers. Comprising a hydrophobic chemotherapeutic drug and a chemosensitizer entrapped within nanoparticles of beta casein (β-CN), which self-associates into micelles.
Israel
Tech
Transfer
Network
1586128594.png)